🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Background: Sickle cell disease (SCD) is an inherited disorder of the bloo...
Status
Active Not Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2022-05-12
Trial ID
NCT05357482
Treatments Being Tested
This is an open-label, single ascending dose Phase 1b/2a trial to determine...
Status
Terminated
Location
Charité - University Clinic Berlin
Start Date
2024-03-18
Trial ID
NCT06353971
Treatments Being Tested
The objective of this clinical trial is to develop a cell therapy for Fanco...
Status
Recruiting
Location
Stanford University
Start Date
2021-12-07
Trial ID
NCT04784052
A Phase 1 study in subjects with LR-MDS to assess the safety and tolerabili...
Status
Terminated
Location
Memorial Healthcare System
Start Date
2023-06-19
Trial ID
NCT05903274
Treatments Being Tested
Background: Sickle cell disease (SCD) is a genetic disorder where red bloo...
Status
Active Not Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2023-12-28
Trial ID
NCT06145282
Treatments Being Tested
This trial will be performed as a three-part dose escalating clinical trial...
Status
Completed
Location
Site 118
Start Date
2023-11-29
Trial ID
NCT06162728
Treatments Being Tested
Background: People with GATA-binding factor 2 (GATA2) deficiency have a mu...
Status
Active Not Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2023-11-29
Trial ID
NCT05907746
Phase 2, open-label, extension study to evaluate the long-term safety, clin...
Status
Terminated
Location
Investigative Site 118
Start Date
2024-11-26
Trial ID
NCT06736262
Treatments Being Tested
Study JSP-CP-012 is designed as a proof of concept, parallel-group, single ...
Status
Terminated
Location
University of Calgary
Start Date
2024-11-26
Trial ID
NCT06592768
Treatments Being Tested